Page last updated: 2024-10-26

enoxacin and Neuroectodermal Tumors, Primitive, Peripheral

enoxacin has been researched along with Neuroectodermal Tumors, Primitive, Peripheral in 1 studies

Enoxacin: A broad-spectrum 6-fluoronaphthyridinone antibacterial agent that is structurally related to NALIDIXIC ACID.
enoxacin : A 1,8-naphthyridine derivative that is 1,4-dihydro-1,8-naphthyridine with an ethyl group at the 1 position, a carboxy group at the 3-position, an oxo sustituent at the 4-position, a fluoro substituent at the 5-position and a piperazin-1-yl group at the 7 position. An antibacterial, it is used in the treatment of urinary-tract infections and gonorrhoea.

Neuroectodermal Tumors, Primitive, Peripheral: A group of highly cellular primitive round cell neoplasms which occur extracranially in soft tissue and bone and are derived from embryonal neural crest cells. These tumors occur primarily in children and adolescents and share a number of characteristics with EWING SARCOMA.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's1 (100.00)2.80

Authors

AuthorsStudies
Kim, JA1
Crawford, KA1
Spada, PA1
Martin, LR1
Zhang, J1
Wong, R1
Reid, JM1
Stewart, CF1
Frank, TM1
Liu, Q1
Michalek, JE1
Keller, C1

Other Studies

1 other study available for enoxacin and Neuroectodermal Tumors, Primitive, Peripheral

ArticleYear
Non-chemotherapy adjuvant agents in TP53 mutant Ewing sarcoma.
    Scientific reports, 2023, 09-01, Volume: 13, Issue:1

    Topics: Adjuvants, Immunologic; Adjuvants, Pharmaceutic; Animals; Benzamides; Disease Models, Animal; Enoxac

2023